MOLECULAR DOCKING STUDIES OF TRIAMCINOLONE DERIVATIVES AGAINST MPB64 GENE RESPONSIBLE FOR EALES DISEASE
Shivani Dixit, Pallavi Gangwar*, Ankur Mohan
ABSTRACT
Eales disease is an idiopathic inflammatory ocular disease that
primarily affects the peripheral retina of adults. Eales disease is
characterised by inflammation(vasculitis), abnormal growth of new
blood vessels (neovascularization), blockage of retinal blood vessels,
capillary non-perfusion, recurrent vitreous hemorrhages, which is the
hallmark of Eales disease. Eales disease mainly involves the peripheral
fundus and occurring predominantly in young and healthy adult males.
The etiology of the disease is unknown but the clinical appearance and
progression are to other diseases of retina such as diabetic and sickle
cell retinopathies. The sequence, structure & functional analysis of the concerned protein
were studied through BLAST and other biological databases. Since, the precise structure of
Immunogenic protein Mpt64 is not yet available, therefore, a theoretical model of the protein
was generated using Easy Modeller 4.0. The best model with DOPE score -15648.14746 was
obtained. Docking studies of various compounds downloaded from drugbank database have
been carried out in the active site of Immunogeneic protein MPB64 by using AutodockVina
4.2. The derivatives designed through chemsketch shows better binding energy [9,18-
difluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione:-14.7 kcal/mol] in comparison
to the drug available in various public databases(Triamcinolone: -14.3 kcal/mol).
Keywords: Ealesdisease, idiopathic, oculardisease, vasculitis, neovascularization, retinalhemorrhages.
[Download Article]
[Download Certifiate]